Welcome to Eric Wang's webpage!
Eric Wang is a senior executive professional with over 30 years’ experience in clinical practice, drug development, and FDA regulatory affairs in academic and industrial settings.
Educated as a medical doctor at China Medical University and trained as a pulmonary disease specialist at Dalian Medical University, Wang began his career as a physician at Dalian Medical University Hospital. Sponsored by Japan-China Medical Association, Wang received clinical training in pulmonary infections at Nagasaki University Medical School in Japan. Later, he studied Medical Product Development and Regulatory Science at University of California, Irvine.
Having been working in the pharmaceutical industry in Southern California since 1996, he has been actively engaged in the areas of R&D, quality, regulatory, clinical development, and strategic planning for company's drug development programs. Currently, he serves as a Board member and Chief Operating Officer of RegenIntel Bioscience, Inc. (Brea, CA) and Executive Vice President of Skingenix, Inc. (Ontario, CA).
Wang is a certified clinical research and FDA regulatory affair professional.
Wang also serves as Advisory Board member of Xu Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School.
He can be reached at email@example.com